Literature DB >> 22142682

Parametric histogram analysis of dynamic contrast-enhanced MRI in multiple myeloma: a technique to evaluate angiogenic response to therapy?

Christian M Zechmann1, Lisa Traine, Tobias Meissner, Barbara Wagner-Gund, Frederik L Giesel, Hartmut Goldschmidt, Stefan Delorme, Jens Hillengass.   

Abstract

RATIONALE AND
OBJECTIVES: From dynamic contrast-enhanced magnetic resonance imaging, it is known that microcirculation patterns in multiple myeloma differ depending on the infiltration pattern. The purpose of this study was to evaluate histogram analysis of dynamic contrast-enhanced magnetic resonance imaging in MM to monitor early treatment response on the basis of microcirculation patterns.
MATERIALS AND METHODS: A total of 51 patients with multiple myeloma requiring therapy were examined. Dynamic contrast-enhanced magnetic resonance imaging of the lumbar spine was performed before and after conventional or high-dose chemotherapy with autologous stem cell transplantation. Statistical analysis included 245 vertebrae and dynamic microcirculation parameters as displayed in histograms. Resulting parameters (amplitude, exchange rate constant, skewness, kurtosis, and left shift) were correlated with therapeutic response.
RESULTS: More than 70% of histograms derived from the microcirculation parameters showed a difference between the maximum peak before and after therapy (left shift). However, there was no significant difference between the particular treatment. Significantly different skewness of amplitude in 98% and kurtosis of exchange rate constant (94.1% and 98%) were seen in the patients who responded to treatment (P for each < .05).
CONCLUSIONS: Histogram analysis revealed early changes after therapy resulting in a shift toward more (kurtosis) and lower values (skewness) of microcirculation parameters. Therefore, histogram analysis can determine and describe if a chosen therapy works at all. However, there were no differences between the chosen therapies. This needs to be reevaluated in a larger number of treated patients. Histogram analysis can also be an adjunct to a subjective visual analysis but is hampered by heterogeneous infiltration pattern seen in multiple myeloma.
Copyright © 2012 AUR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22142682     DOI: 10.1016/j.acra.2011.09.007

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  6 in total

1.  Whole-body MRI and PET/CT in multiple myeloma patients during staging and after treatment: personal experience in a longitudinal study.

Authors:  Giuseppe Lucio Cascini; Carmela Falcone; Domenico Console; Antonino Restuccia; Marco Rossi; Antonello Parlati; Oscar Tamburrini
Journal:  Radiol Med       Date:  2013-06-26       Impact factor: 3.469

Review 2.  Whole-body MRI, dynamic contrast-enhanced MRI, and diffusion-weighted imaging for the staging of multiple myeloma.

Authors:  Julie C Dutoit; Koenraad L Verstraete
Journal:  Skeletal Radiol       Date:  2017-03-13       Impact factor: 2.199

3.  Diagnosis of Spinal Lesions Using Heuristic and Pharmacokinetic Parameters Measured by Dynamic Contrast-Enhanced MRI.

Authors:  Ning Lang; Huishu Yuan; Hon J Yu; Min-Ying Su
Journal:  Acad Radiol       Date:  2017-02-02       Impact factor: 3.173

Review 4.  MRI in multiple myeloma: a pictorial review of diagnostic and post-treatment findings.

Authors:  Julie C Dutoit; Koenraad L Verstraete
Journal:  Insights Imaging       Date:  2016-05-10

5.  (18)F-FDG-PET/CT imaging in an IL-6- and MYC-driven mouse model of human multiple myeloma affords objective evaluation of plasma cell tumor progression and therapeutic response to the proteasome inhibitor ixazomib.

Authors:  K Duncan; T R Rosean; V S Tompkins; A Olivier; R Sompallae; F Zhan; G Tricot; M R Acevedo; L L B Ponto; S A Walsh; L T Tygrett; A J Berger; T Waldschmidt; H C Morse; J J Sunderland; S Janz
Journal:  Blood Cancer J       Date:  2013-11-29       Impact factor: 11.037

Review 6.  Imaging of treatment response and minimal residual disease in multiple myeloma: state of the art WB-MRI and PET/CT.

Authors:  Frederic E Lecouvet; Marie-Christiane Vekemans; Thomas Van Den Berghe; Koenraad Verstraete; Thomas Kirchgesner; Souad Acid; Jacques Malghem; Joris Wuts; Jens Hillengass; Vincent Vandecaveye; François Jamar; Olivier Gheysens; Bruno C Vande Berg
Journal:  Skeletal Radiol       Date:  2021-08-07       Impact factor: 2.199

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.